Table 4.
Analysis Clinical Endpoint by Osteoprotegerin Levels
| Model | HR (95% CI)a | |||
|---|---|---|---|---|
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |
| No. of events (n) | 14 | 16 | 30 | 39 |
| Univariate analysis | 1.00 | 1.05 (0.50, 2.16) | 1.94 (1.03, 3.65) | 2.98 (1.62, 5.49) |
| Multivariate analysisb | 1.00 | 0.94 (0.44, 1.99) | 1.34 (0.67, 2.70) | 2.49 (1.26, 4.89) |
Abbreviations: CCB, calcium channel blocker; CI, confidence interval; DM, diabetes mellitus; HDL‐C, high‐density lipoprotein cholesterol; HR, hazard ratio; hs‐CRP, high‐sensitivity C‐reactive protein.
a
HR per quartile.
b
Cox proportional hazard model adjusted for age, gender, hypertension, DM, dyslipidemia, smoking, hs‐CRP, percent area stenosis, HDL‐C, and use of CCB.